XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A Profit Margin

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A posts a profit margin of 64.89% as of March 2026. That compares with -7.82% in the prior-year period — up 929.3% year over year. That is above the Healthcare sector average of 14.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's profit margin was -7.82%. The latest reading is 64.89% — a 929.3% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 14.34% is typical. XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's 64.89% is higher that level. That is roughly 352.4% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 64.89% as of March 2026; use YoY and peer views to separate noise from signal.

Context for XOMAP's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 14.34%), and (3) consistency with growth and profitability. This page covers the first two; XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's other metric pages and overview cover the third.